58 related articles for article (PubMed ID: 22674302)
1. Association of D4-GDI expression with breast cancer progression.
Rivera Rosado LA; Rodriguez-Canales J; Zhang B
Cancer Biomark; 2011-2012; 10(3-4):163-73. PubMed ID: 22674302
[TBL] [Abstract][Full Text] [Related]
2. D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness.
Zhang Y; Zhang B
Cancer Res; 2006 Jun; 66(11):5592-8. PubMed ID: 16740694
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 is a target gene of rho GDP dissociation inhibitor beta in breast cancer cells.
Schunke D; Span P; Ronneburg H; Dittmer A; Vetter M; Holzhausen HJ; Kantelhardt E; Krenkel S; Müller V; Sweep FC; Thomssen C; Dittmer J
Cancer Res; 2007 Nov; 67(22):10694-702. PubMed ID: 18006811
[TBL] [Abstract][Full Text] [Related]
4. Mutated D4-guanine diphosphate-dissociation inhibitor is found in human leukemic cells and promotes leukemic cell invasion.
Nakata Y; Kondoh K; Fukushima S; Hashiguchi A; Du W; Hayashi M; Fujimoto J; Hata J; Yamada T
Exp Hematol; 2008 Jan; 36(1):37-50. PubMed ID: 18037226
[TBL] [Abstract][Full Text] [Related]
5. Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling.
Zhang Y; Rivera Rosado LA; Moon SY; Zhang B
J Biol Chem; 2009 May; 284(19):12956-65. PubMed ID: 19269969
[TBL] [Abstract][Full Text] [Related]
6. KAI1 protein is down-regulated during the progression of human breast cancer.
Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
[TBL] [Abstract][Full Text] [Related]
7. Altered cellular immunity in transgenic mice with T cell-specific expression of human D4-guanine diphosphate-dissociation inhibitor (D4-GDI).
Kondoh K; Nakata Y; Yamaoka T; Itakura M; Hayashi M; Yamada K; Hata J; Yamada T
Int Immunol; 2008 Oct; 20(10):1299-311. PubMed ID: 18689726
[TBL] [Abstract][Full Text] [Related]
8. Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis.
Hu LD; Zou HF; Zhan SX; Cao KM
Oncol Rep; 2007 Jun; 17(6):1383-9. PubMed ID: 17487395
[TBL] [Abstract][Full Text] [Related]
9. Rho GDP dissociation inhibitor alpha expression correlates with the outcome of CMF treatment in invasive ductal breast cancer.
Ronneburg H; Span PN; Kantelhardt E; Dittmer A; Schunke D; Holzhausen HJ; Sweep FC; Dittmer J
Int J Oncol; 2010 Feb; 36(2):379-86. PubMed ID: 20043072
[TBL] [Abstract][Full Text] [Related]
10. Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer.
Lee JE; Kim HJ; Bae JY; Kim SW; Park JS; Shin HJ; Han W; Kim SW; Kang KS; Noh DY
BMC Cancer; 2005 Dec; 5():154. PubMed ID: 16324219
[TBL] [Abstract][Full Text] [Related]
11. Cleavage and nuclear translocation of the caspase 3 substrate Rho GDP-dissociation inhibitor, D4-GDI, during apoptosis.
Krieser RJ; Eastman A
Cell Death Differ; 1999 May; 6(5):412-9. PubMed ID: 10381642
[TBL] [Abstract][Full Text] [Related]
12. GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis.
Essmann F; Wieder T; Otto A; Müller EC; Dörken B; Daniel PT
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):777-83. PubMed ID: 10698706
[TBL] [Abstract][Full Text] [Related]
13. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
[TBL] [Abstract][Full Text] [Related]
14. Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome.
Hsing CH; Cheng HC; Hsu YH; Chan CH; Yeh CH; Li CF; Chang MS
Clin Cancer Res; 2012 Feb; 18(3):713-25. PubMed ID: 22186257
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers.
Jiang WG; Watkins G; Lane J; Cunnick GH; Douglas-Jones A; Mokbel K; Mansel RE
Clin Cancer Res; 2003 Dec; 9(17):6432-40. PubMed ID: 14695145
[TBL] [Abstract][Full Text] [Related]
16. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
17. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of HOX genes in human invasive breast carcinoma.
Makiyama K; Hamada J; Takada M; Murakawa K; Takahashi Y; Tada M; Tamoto E; Shindo G; Matsunaga A; Teramoto K; Komuro K; Kondo S; Katoh H; Koike T; Moriuchi T
Oncol Rep; 2005 Apr; 13(4):673-9. PubMed ID: 15756441
[TBL] [Abstract][Full Text] [Related]
19. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
